These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32266388)

  • 21. Perspectives on synthetic pharmacotherapy for the treatment of nosocomial pneumonia.
    Motos A; Yang H; Yang M; Torres A
    Expert Opin Pharmacother; 2019 Aug; 20(12):1439-1448. PubMed ID: 31095426
    [No Abstract]   [Full Text] [Related]  

  • 22. Is hospital-acquired pneumonia different in transplant recipients?
    Gudiol C; Sabé N; Carratalà J
    Clin Microbiol Infect; 2019 Oct; 25(10):1186-1194. PubMed ID: 30986554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aetiology of hospital-acquired pneumonia and trends in antimicrobial resistance.
    Enne VI; Personne Y; Grgic L; Gant V; Zumla A
    Curr Opin Pulm Med; 2014 May; 20(3):252-8. PubMed ID: 24614243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is antipseudomonal antibiotic treatment needed for all nursing and healthcare-associated pneumonia patients at risk for antimicrobial resistance?
    Ito A; Ishida T; Tachibana H; Nakanishi Y; Yamazaki A; Washio Y
    J Glob Antimicrob Resist; 2020 Sep; 22():441-447. PubMed ID: 32339851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased β-Lactams dosing regimens improve clinical outcome in critically ill patients with augmented renal clearance treated for a first episode of hospital or ventilator-acquired pneumonia: a before and after study.
    Carrié C; Chadefaux G; Sauvage N; de Courson H; Petit L; Nouette-Gaulain K; Pereira B; Biais M
    Crit Care; 2019 Nov; 23(1):379. PubMed ID: 31775840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection reduction strategies including antibiotic stewardship protocols in surgical and trauma intensive care units are associated with reduced resistant gram-negative healthcare-associated infections.
    Dortch MJ; Fleming SB; Kauffmann RM; Dossett LA; Talbot TR; May AK
    Surg Infect (Larchmt); 2011 Feb; 12(1):15-25. PubMed ID: 21091186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens.
    Leroy O; Giradie P; Yazdanpanah Y; Georges H; Alfandari S; Sanders V; Devos P; Beaucaire G
    Eur Respir J; 2002 Aug; 20(2):432-9. PubMed ID: 12212978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections.
    Lodise TP; Bonine NG; Ye JM; Folse HJ; Gillard P
    BMC Infect Dis; 2019 Aug; 19(1):718. PubMed ID: 31412809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential Impact of Rapid Multiplex PCR on Antimicrobial Therapy Guidance for Ventilated Hospital-Acquired Pneumonia in Critically Ill Patients, A Prospective Observational Clinical and Economic Study.
    Guillotin F; Poulain C; Gaborit B; Bouras M; Cinotti R; Lakhal K; Vourc'h M; Rozec B; Asehnoune K; Vibet MA; Riche VP; Gibaud SA; Crémet L; Roquilly A
    Front Cell Infect Microbiol; 2022; 12():804611. PubMed ID: 35493730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An overview of guidelines for the management of hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria.
    Cillóniz C; Dominedò C; Torres A
    Curr Opin Infect Dis; 2019 Dec; 32(6):656-662. PubMed ID: 31567412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should the patients colonized with extended-spectrum beta-lactamase-producing Gram-negative bacilli (E-GNB) coming to hospital from the community with pneumonia get anti-E-GNB active empirical treatment?
    Peterlin L; Žagar M; Lejko Zupanc T; Paladin M; Beović B
    J Chemother; 2017 Oct; 29(5):287-291. PubMed ID: 27905262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical pharmacotherapy for hospital-acquired pneumonia in the elderly.
    Burgos J; Falcó V; Almirante B
    Expert Opin Pharmacother; 2019 Mar; 20(4):423-434. PubMed ID: 30614744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healthcare-Associated Pneumonia and Hospital-Acquired Pneumonia: Bacterial Aetiology, Antibiotic Resistance and Treatment Outcomes: A Study From North India.
    Kumar S; Jan RA; Fomda BA; Rasool R; Koul P; Shah S; Khan UH; Qadri SM; Masoodi SR; Mantoo S; Muzamil M
    Lung; 2018 Aug; 196(4):469-479. PubMed ID: 29691645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients.
    Warren DK; Hill HA; Merz LR; Kollef MH; Hayden MK; Fraser VJ; Fridkin SK
    Crit Care Med; 2004 Dec; 32(12):2450-6. PubMed ID: 15599150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pneumonia observational incidence and treatment: a multidisciplinary process improvement study.
    Brozek J; McDonald E; Clarke F; Gosse C; Jaeschke R; Cook D
    Am J Crit Care; 2007 May; 16(3):214-9. PubMed ID: 17460312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftobiprole for the treatment of pneumonia: a European perspective.
    Liapikou A; Cillóniz C; Torres A
    Drug Des Devel Ther; 2015; 9():4565-72. PubMed ID: 26316697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.
    Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ
    Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current guidelines for the treatment of severe pneumonia and sepsis.
    Bodmann KF
    Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A successful program preventing nonventilator hospital-acquired pneumonia in a large hospital system.
    Lacerna CC; Patey D; Block L; Naik S; Kevorkova Y; Galin J; Parker M; Betts R; Parodi S; Witt D
    Infect Control Hosp Epidemiol; 2020 May; 41(5):547-552. PubMed ID: 31939344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.